Skip to main content
. 2016 Jan 29;37(3):1080–1090. doi: 10.1002/hbm.23085

Figure 2.

Figure 2

Correlation between SUV changes in the PFC and the amygdala. This correlation was observed most significantly in the patients receiving active ketamine treatment (bottom left figure) (P < 0.05). However, this correlation was not observed in the placebo group, suggesting that the antidepressant mechanisms of the placebo differ from the antidepressant mechanisms of ketamine.